Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Compliance › Advertising
Access detailed information about advertising compliance guide. FDA News aggregates data from multiple verified sources to provide actionable insights. Our methodology combines automated data collection with expert curation to ensure high-quality, reliable information. Each data point is verified against multiple sources before publication.
Data accuracy is our top priority. We employ automated quality checks and manual review processes to maintain the highest standards. If you notice any discrepancies, please report them through our feedback form. Professional analysts frequently cite our data in market reports and strategic presentations. Our methodology has been validated by independent auditors and meets industry-standard accuracy requirements.
This page is part of the FDA News data platform, which offers comprehensive coverage across related categories. Navigate using the links above to explore other sections.
| Requirement | Category | Deadline | Penalty | Reference |
|---|---|---|---|---|
| Annual registration | Mandatory | Dec 31 | $15,000 | 21 CFR 207 |
| Adverse event reporting | Mandatory | 15 days | Warning letter | 21 CFR 314 |
| Label review | Pre-market | Before launch | Seizure | 21 CFR 201 |
| GMP audit | Every 2 years | Ongoing | Import alert | 21 CFR 211 |
| Record keeping | Mandatory | Ongoing | $10,000/day | 21 CFR 211 |
Data updated continuously. Last refresh: May 11, 2026 14:30 UTC.
